Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria

Antimicrob Agents Chemother. 1995 Apr;39(4):990-5. doi: 10.1128/AAC.39.4.990.

Abstract

The in vitro activity of a prototype 2-aryl carbapenem, L-695,256, against gram-positive bacteria was examined. All streptococci and oxacillin-susceptible and -resistant staphylococci were inhibited at concentrations of < or = 0.125, < or = 0.125, and 4 micrograms/ml, respectively. The activity of L-695,256 was superior to that of imipenem against other organisms intrinsically resistant to beta-lactams.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • Gram-Positive Bacteria / drug effects*
  • Imidazoles / pharmacology
  • Methicillin Resistance
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Imidazoles
  • L 695256